#VisualAbstract: Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
1. While well-tolerated in early and mild Alzheimer’s disease, the BACE1 inhibitor lanabecestat was generally ineffective in slowing cognitive and ...